Literature DB >> 34716216

Detection of PKD1 and PKD2 Somatic Variants in Autosomal Dominant Polycystic Kidney Cyst Epithelial Cells by Whole-Genome Sequencing.

Zhengmao Zhang1, Hanwen Bai2, Jon Blumenfeld3,4, Andrew B Ramnauth1, Irina Barash3,4, Martin Prince5, Adrian Y Tan1,3, Alber Michaeel1, Genyan Liu1, Ines Chicos4, Lior Rennert6, Stavros Giannakopoulos7, Karen Larbi7, Stuart Hughes7, Steven P Salvatore1, Brian D Robinson1, Sandip Kapur8, Hanna Rennert9.   

Abstract

BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disorder characterized by the development of multiple cysts in the kidneys. It is often caused by pathogenic mutations in PKD1 and PKD2 genes that encode polycystin proteins. Although the molecular mechanisms for cystogenesis are not established, concurrent inactivating germline and somatic mutations in PKD1 and PKD2 have been previously observed in renal tubular epithelium (RTE).
METHODS: To further investigate the cellular recessive mechanism of cystogenesis in RTE, we conducted whole-genome DNA sequencing analysis to identify germline variants and somatic alterations in RTE of 90 unique kidney cysts obtained during nephrectomy from 24 unrelated participants.
RESULTS: Kidney cysts were overall genomically stable, with low burdens of somatic short mutations or large-scale structural alterations. Pathogenic somatic "second hit" alterations disrupting PKD1 or PKD2 were identified in 93% of the cysts. Of these, 77% of cysts acquired short mutations in PKD1 or PKD2; specifically, 60% resulted in protein truncations (nonsense, frameshift, or splice site) and 17% caused non-truncating mutations (missense, in-frame insertions, or deletions). Another 18% of cysts acquired somatic chromosomal loss of heterozygosity (LOH) events encompassing PKD1 or PKD2 ranging from 2.6 to 81.3 Mb. 14% of these cysts harbored copy number neutral LOH events, while the other 3% had hemizygous chromosomal deletions. LOH events frequently occurred at chromosomal fragile sites, or in regions comprising chromosome microdeletion diseases/syndromes. Almost all somatic "second hit" alterations occurred at the same germline mutated PKD1/2 gene.
CONCLUSIONS: These findings further support a cellular recessive mechanism for cystogenesis in ADPKD primarily caused by inactivating germline and somatic variants of PKD1 or PKD2 genes in kidney cyst epithelium.
Copyright © 2021 by the American Society of Nephrology.

Entities:  

Keywords:  ADPKD; autosomal dominant; cystic kidney; cysts; end-stage renal disease; epithelial cells; genetic renal disease; polycystic kidney; polycystic kidney disease; whole genome sequencing

Year:  2021        PMID: 34716216      PMCID: PMC8638386          DOI: 10.1681/ASN.2021050690

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  50 in total

1.  Somatic PKD2 mutations in individual kidney and liver cysts support a "two-hit" model of cystogenesis in type 2 autosomal dominant polycystic kidney disease.

Authors:  Y Pei; T Watnick; N He; K Wang; Y Liang; P Parfrey; G Germino; P St George-Hyslop
Journal:  J Am Soc Nephrol       Date:  1999-07       Impact factor: 10.121

2.  A novel long-range PCR sequencing method for genetic analysis of the entire PKD1 gene.

Authors:  Ying-Cai Tan; Alber Michaeel; Jon Blumenfeld; Stephanie Donahue; Tom Parker; Daniel Levine; Hanna Rennert
Journal:  J Mol Diagn       Date:  2012-05-16       Impact factor: 5.568

3.  Whole-genome sequencing overcomes pseudogene homology to diagnose autosomal dominant polycystic kidney disease.

Authors:  Amali C Mallawaarachchi; Yvonne Hort; Mark J Cowley; Mark J McCabe; André Minoche; Marcel E Dinger; John Shine; Timothy J Furlong
Journal:  Eur J Hum Genet       Date:  2016-05-11       Impact factor: 4.246

Review 4.  Genetics and pathogenesis of autosomal dominant polycystic kidney disease: 20 years on.

Authors:  Emilie Cornec-Le Gall; Marie-Pierre Audrézet; Yannick Le Meur; Jian-Min Chen; Claude Férec
Journal:  Hum Mutat       Date:  2014-12       Impact factor: 4.878

Review 5.  Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease.

Authors:  Peter C Harris; Vicente E Torres
Journal:  J Clin Invest       Date:  2014-06-02       Impact factor: 14.808

6.  Predicting the functional effect of amino acid substitutions and indels.

Authors:  Yongwook Choi; Gregory E Sims; Sean Murphy; Jason R Miller; Agnes P Chan
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

Review 7.  Mechanisms and regulation of mitotic recombination in Saccharomyces cerevisiae.

Authors:  Lorraine S Symington; Rodney Rothstein; Michael Lisby
Journal:  Genetics       Date:  2014-11       Impact factor: 4.562

Review 8.  Tumor Suppressor Genes within Common Fragile Sites Are Active Players in the DNA Damage Response.

Authors:  Idit Hazan; Thomas G Hofmann; Rami I Aqeilan
Journal:  PLoS Genet       Date:  2016-12-15       Impact factor: 5.917

Review 9.  Insights into Autosomal Dominant Polycystic Kidney Disease from Genetic Studies.

Authors:  Matthew B Lanktree; Amirreza Haghighi; Ighli di Bari; Xuewen Song; York Pei
Journal:  Clin J Am Soc Nephrol       Date:  2020-07-20       Impact factor: 8.237

10.  Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics.

Authors:  Kiyomi Morita; Feng Wang; Katharina Jahn; Tianyuan Hu; Tomoyuki Tanaka; Yuya Sasaki; Jack Kuipers; Sanam Loghavi; Sa A Wang; Yuanqing Yan; Ken Furudate; Jairo Matthews; Latasha Little; Curtis Gumbs; Jianhua Zhang; Xingzhi Song; Erika Thompson; Keyur P Patel; Carlos E Bueso-Ramos; Courtney D DiNardo; Farhad Ravandi; Elias Jabbour; Michael Andreeff; Jorge Cortes; Kapil Bhalla; Guillermo Garcia-Manero; Hagop Kantarjian; Marina Konopleva; Daisuke Nakada; Nicholas Navin; Niko Beerenwinkel; P Andrew Futreal; Koichi Takahashi
Journal:  Nat Commun       Date:  2020-10-21       Impact factor: 17.694

View more
  4 in total

1.  Monoallelic pathogenic ALG5 variants cause atypical polycystic kidney disease and interstitial fibrosis.

Authors:  Hugo Lemoine; Loann Raud; François Foulquier; John A Sayer; Baptiste Lambert; Eric Olinger; Siriane Lefèvre; Bertrand Knebelmann; Peter C Harris; Pascal Trouvé; Aurore Desprès; Gabrielle Duneau; Marie Matignon; Anais Poyet; Noémie Jourde-Chiche; Dominique Guerrot; Sandrine Lemoine; Guillaume Seret; Miguel Barroso-Gil; Coralie Bingham; Rodney Gilbert; Yannick Le Meur; Marie-Pierre Audrézet; Emilie Cornec-Le Gall
Journal:  Am J Hum Genet       Date:  2022-07-26       Impact factor: 11.043

Review 2.  AMPK and Polycystic Kidney Disease Drug Development: An Interesting Off-Target Target.

Authors:  Michael J Caplan
Journal:  Front Med (Lausanne)       Date:  2022-01-31

Review 3.  Recent Discoveries in Epigenetic Modifications of Polycystic Kidney Disease.

Authors:  Sarah A Bowden; Euan J Rodger; Aniruddha Chatterjee; Michael R Eccles; Cherie Stayner
Journal:  Int J Mol Sci       Date:  2021-12-11       Impact factor: 5.923

4.  Identification of Genetic Risk Factors of Severe COVID-19 Using Extensive Phenotypic Data: A Proof-of-Concept Study in a Cohort of Russian Patients.

Authors:  Sergey G Shcherbak; Anton I Changalidi; Yury A Barbitoff; Anna Yu Anisenkova; Sergei V Mosenko; Zakhar P Asaulenko; Victoria V Tsay; Dmitrii E Polev; Roman S Kalinin; Yuri A Eismont; Andrey S Glotov; Evgeny Y Garbuzov; Alexander N Chernov; Olga A Klitsenko; Mikhail O Ushakov; Anton E Shikov; Stanislav P Urazov; Vladislav S Baranov; Oleg S Glotov
Journal:  Genes (Basel)       Date:  2022-03-17       Impact factor: 4.141

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.